Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method

Biotechnology Letters

Volumn 30, Issue 5, 2008, Pages 829-834

  Hasegawa, Hijiri ^a   Sode, Koji ^a   Ikebukuro, Kazunori ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Aptamer blotting; Cancer diagnosis; Competitor; DNA aptamer; Sensor element; VEGF165

Indexed keywords

APTAMER BLOTTING; DNA APTAMER; SENSOR ELEMENT;

ENDOTHELIAL CELLS; GROWTH KINETICS; PROTEINS; TUMORS;

DNA SEQUENCES;

APTAMER; IMMOBILIZED ENZYME; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BINDING COMPETITION; COMBINATORIAL CHEMISTRY; CONFORMATION; GENE LIBRARY; GENETIC PROCEDURES; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; SURFACE PLASMON RESONANCE;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BINDING, COMPETITIVE; ENZYMES, IMMOBILIZED; GENE LIBRARY; HUMANS; MOLECULAR PROBE TECHNIQUES; NUCLEIC ACID CONFORMATION; SELEX APTAMER TECHNIQUE; SURFACE PLASMON RESONANCE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41549162934     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-007-9629-6     Document Type: Article

References (16)

1. Bhisitkul RB (2006) Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol 90:1542-1547
2. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L (2003) A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci USA 100:15416-15421
3. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822
4. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676
5. Igarashi S, Ohtera T, Yoshida H, Witarto AB, Sode K (1999) Construction and characterization of mutant water-soluble PQQ glucose dehydrogenases with altered K(m) values-site-directed mutagenesis studies on the putative active site. Biochem Biophys Res Commun 26:820-824
6. Ikebukuro K, Kiyohara C, Sode K (2005) Novel electrochemical sensor system for protein using the aptamers in sandwich manner. Biosens Bioelectron 20:2168-2172
7. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271:7788-7795
8. 165. Proc Natl Acad Sci USA 102:18902-18907
9. Mathews DH, Sabina J, Zuker M, Turner DH (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288:911-940
10. Nguyen M (1997) Angiogenic factors as tumor markers. Invest New Drugs 15:29-37
11. Noma T, Ikebukuro K, Sode K, Ohkubo T, Sakasegawa Y, Hachiya N, Kaneko K (2006) A screening method for DNA aptamers that bind to a specific, unidentified protein in tissue samles. Biotechnol Lett 28:1377-1381
12. 165). J Biol Chem 273:20556-20567
13. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745
14. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510
15. Wang C, Zhang M, Yang G, Zhang D, Ding H, Wang H, Fan M, Shen B, Shao N (2003) Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol 102:15-22
16. Yoshida W, Sode K, Ikebukuro K (2006) Aptameric enzyme subunit for biosensing based on enzymatic activity measurement. Anal Chem 78:3296-3303